Treatment of kaposi's sarcoma with vinblastine

Edmund Klein, Robert Allen Schwartz, Yona Laor, Halina Milgrom, Gordon H. Burgess, Ole A. Holtermann

Research output: Contribution to journalArticlepeer-review

64 Scopus citations

Abstract

Fourteen patients with Kaposi's sarcoma (KS) were treated systemically with vinblastine sulfate in a low‐dose regimen and compared with 23 patients reported in the medical literature. The therapeutic results in our series were excellent in terms of regression of cutaneous lesions. Vinblastine appears to be a drug that is well suited for the management of KS in an outpatient setting. Intravenous therapy may be supplemented with intralesional or intraarterial vinblastine.

Original languageEnglish (US)
Pages (from-to)427-431
Number of pages5
JournalCancer
Volume45
Issue number3
DOIs
StatePublished - Feb 1 1980
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Treatment of kaposi's sarcoma with vinblastine'. Together they form a unique fingerprint.

Cite this